News

@UofGCancerSci

@UofGCancerSci

University of Glasgow sign outside front entrance
University of Glasgow sign outside front entrance

PRIMUS-006 Pancreatic Cancer Study

Wed, 19 Jun 2024 12:58:00 BST

The University of Glasgow, alongside NHS Greater Glasgow & Clyde, has opened the PRIMUS-006 pancreatic cancer study, part of the Precision-Panc Platform.

Laptop on desk with books
Laptop on desk with books

A new AI-powered system developed by researchers

Wed, 12 Jun 2024 11:42:00 BST

A computer system which harnesses the power of AI to learn the language of cancer is capable of spotting the signs of the disease in biological samples with remarkable accuracy, its developers say.

Sign outside the Wolfson Wohl Cancer Research Centre
Sign outside the Wolfson Wohl Cancer Research Centre

The PancAim Project

Wed, 25 Oct 2023 12:56:00 BST

The PancAim project, which aims to use artificial intelligence (AI) to improve Pancreatic Cancer treatment, will soon realise the broad implementation of a novel AI algorithm for earlier detection of the disease on CT.

Beatson Institute at Garscube campus
Beatson Institute at Garscube campus

Scientists unlock secrets of the aging process

Wed, 25 Oct 2023 13:02:00 BST

How we grow old gracefully – and whether we can do anything to slow down the process – has long been a fascination of humanity. However, despite continued research the answer to how we can successfully combat ageing still remains elusive.

Beatson Institute at Garscube campus
Beatson Institute at Garscube campus

Cancer Research UK investment in Scotland

Wed, 20 Sep 2023 11:33:00 BST

Cancer Research UK has announced its largest ever investment in Scotland of up to £123m, for the CRUK Scotland Institute (formerly known as the Cancer Research UK Beatson Institute)

the University Tower and trees in Kelvingrove Park
the University Tower and trees in Kelvingrove Park

Major CRUK clinical trial has launched in Scotland.

Wed, 06 Sep 2023 09:59:00 BST

A major Cancer Research UK clinical trial aiming to find effective new treatments for patients with rare forms of the disease has launched in Scotland. The DETERMINE trial will match people who have rare cancers, or cancers with rare genetic faults, with existing medications already being used to treat other cancers.

Researchers working in a lab
Researchers working in a lab

Diabetes drug may offer new treatment hope for chronic myeloid leukaemia

Wed, 30 Aug 2023 15:06:00 BST

A drug being developed to combat metabolic diseases such as type 2 diabetes and Alzheimer’s disease may offer new treatment hope for people with chronic myeloid leukaemia (CML), a form of blood cancer.

Sign outside the Wolfson Wohl Cancer Research Centre
Sign outside the Wolfson Wohl Cancer Research Centre

MPs learn about vital cancer research at Glasgow

Wed, 30 Aug 2023 15:11:24 BST

The University of Glasgow welcomed a delegation of politicians to the Wolfson Wohl Cancer Research Centre at the Garscube Campus to showcase the cutting-edge research taking place in the School of Cancer Sciences and the Beatson Institute for Cancer Research.

A Wolfson Wohl lab worker looks through a microscope
A Wolfson Wohl lab worker looks through a microscope

Bowel cancer mystery solved by Glasgow scientists

Wed, 30 Aug 2023 15:15:33 BST

A mystery which has stumped bowel cancer researchers for decades, has been solved by scientists at the Cancer Research UK Beatson Institute and University of Glasgow. Generations of doctors and researchers have struggled to understand why a bowel cancer patient’s immune system ignores the cancer, rather than attack it.

A Wolfson Wohl worker views a monitor
A Wolfson Wohl worker views a monitor

Major funding boost for cutting-edge leukaemia research

Wed, 30 Aug 2023 15:20:38 BST

Scientists from across the UK are hoping to learn how they can better predict leukaemia (blood cancer) occurrence, as well as develop improved drug screening pathways to treat the disease, through a major funding boost worth £12million.

Beatson Institute at Garscube campus
Beatson Institute at Garscube campus

University of Glasgow scientists are to receive £1.7m from Cancer Research UK to investigate both the root causes of cancer and how treatments can be improved.

Wed, 21 Dec 2022 11:50:00 GMT

Professor Stephen Tait, of the Cancer Research UK Beatson Institute and the Glasgow University School of Cancer Sciences, will receive £1,646,832 to investigate what causes cancer cells to grow out of control and form tumours. While Dr Conchita Vens, who is based at the Wolfson Wohl Cancer Centre, will receive £99,000 to explore how to overcome cancers which are resistant to radiotherapy.

CRUK RadNet Glasgow Centre Launch Event

Fri, 18 Sep 2020 16:12:00 BST

CRUK RadNet Glasgow Centre Launch Event, 2nd October 2020, 10am-4pm

A Wolfson Wohl lab worker looks through a microscope
A Wolfson Wohl lab worker looks through a microscope

MVLS Engagement Team Updates - April 2020 - COVID-19 and Public Engagement

Thu, 09 Apr 2020 10:40:41 BST

The MVLS Public Engagement Team have provided a list of FAQ’s related to public engagement and our coronavirus response are available at Coronavirus: FAQS For MVLS Staff.

University of Glasgow Main Building from Kelvinbridge
University of Glasgow Main Building from Kelvinbridge

Coronavirus: Information for Staff and Students

Mon, 30 Mar 2020 12:13:00 BST

Updated information for staff and students

New Glasgow Cancer Tests for Research and Clinical Trials

Tue, 05 Nov 2019 11:04:00 GMT

The Glasgow Precision Oncology Laboratory (GPOL) at the University of Glasgow has developed a ground-breaking new cancer test for research and clinical trials that could ultimately change the way cancer medicine is delivered.

UofG scientists lead the way in next generation radiotherapy research

Tue, 05 Nov 2019 15:50:00 GMT

GLASGOW scientists have been awarded a major cash boost from Cancer Research UK to pioneer new radiotherapy technologies and techniques that could help more people survive cancer in the future.

Sign outside the Wolfson Wohl Cancer Research Centre
Sign outside the Wolfson Wohl Cancer Research Centre

Professor Andrew Biankin is awarded an Order of Australia (AO) in the Australian Queen’s Birthday Honours

Tue, 11 Jun 2019 13:14:00 BST

Congratulations to Professor Andrew Biankin on being awarded an Order of Australia (AO) in the Australian Queen’s Birthday Honours

Overhaul of clinical training in Scotland to help retain women in the field

Tue, 14 May 2019 14:54:00 BST

Scottish science is set to receive a multimillion pound boost to transform training for doctors who undertake cancer research. Cancer Research UK is to award over £6 million to its research centres in Glasgow and Edinburgh to train early-career clinician scientists.

Glasgow Precision Oncology Laboratory

Tue, 30 Apr 2019 15:49:00 BST

Glasgow Precision Oncology Laboratory is leading the way in precision medicine for cancer

Scientists break new ground in potential treatment of common form of leukaemia

Wed, 19 Dec 2018 14:40:00 GMT

Scientists at the University of Glasgow have discovered a potential combination therapy for the treatment of chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in the Western world, diagnosed in more than 3,500 people in the UK each year.

MVLS Images with Impact Competition 2018

Mon, 01 Oct 2018 13:24:00 BST

The MVLS Images with Impact 2018 competition was launched on 1st October 2018. This competition encourages staff and students to submit images, the winner being used as the front of the College Christmas Card 2018.

CML
CML

£3m award for pioneering Scottish leukaemia trial

Fri, 17 Aug 2018 09:32:00 BST

University of Glasgow scientists are set to receive £3m funding to help more patients survive a rare form of blood cancer.

Exterior of the Wolfson Medical School building - day
Exterior of the Wolfson Medical School building - day

Scientists identify why some kidney transplants don’t work

Tue, 21 Aug 2018 15:52:00 BST

Scientists have discovered a ‘molecular signature’ for the allostatic load – or ‘wear and tear’ of kidneys – which could help clinicians understand why some kidney transplants don’t work as well as expected.

The Scottish Genomics Partnership was featured in the Scotsman

Tue, 17 Jul 2018 12:20:00 BST

The Scottish Genomics Partnership has been mentioned on the front page of the Scotsman as well as a full page story inside.

Sign outside the Wolfson Wohl Cancer Research Centre
Sign outside the Wolfson Wohl Cancer Research Centre

UK Oncology Forum 2018

Fri, 17 Aug 2018 14:13:00 BST

Prof Jeff Evans intervew with VJOncology - Pancreatic Cancer: Where are we now?

POGLRC
POGLRC

New Director of the Paul O'Gorman Leukaemia Research Centre

Wed, 07 Mar 2018 15:16:00 GMT

Mhairi Copland, Professor of Translational Haematology and Honorary Consultant Haematologist has recently taken over as Director of the Paul O'Gorman Leukaemia Research Centre and Head of Experimental Haematology Section

Translating Science to the Clinic
Translating Science to the Clinic

Cancer Research UK Clinical Trials Unit (CTU) awarded £4.5m funding grant

Fri, 16 Feb 2018 15:25:00 GMT

University of Glasgow scientists are set to receive a major grant for pioneering research into cancer. Cancer Research UK is planning to invest nearly £4.5 million over the next five years in ground-breaking work at the Cancer Research UK Clinical Trials Unit (CTU) in Glasgow. The grant will allow doctors and scientists to continue researching and testing better and kinder treatments for patients.

Anti-cancer breakthrough CICD can eradicate tumours

Tue, 29 Aug 2017 10:10:00 BST

Anti-cancer breakthrough CICD can eradicate tumours. A newly discovered process to kill cancer cells can eradicate tumours and reduce the risk of side effects and recurrence of the disease, scientists say.

Two MVLS institutes gain a Bronze Athena SWAN Award

Mon, 08 May 2017 08:00:00 BST

The Institute of Cancer Sciences (ICS) and the Institute of Molecular, Cell and Systems Biology (IMCSB) have become the latest University of Glasgow recipients of a prestigious Athena SWAN Bronze award today, 8 May 2017.

Scientists create leukaemia online tool to aid global search for cure

Tue, 09 May 2017 15:17:00 BST

Finding a cure for chronic myeloid leukaemia (CML) could be accelerated by a new virtual platform that allows researchers easy access to data from patient samples generated by laboratories around the world. LEUKomics, which has been launched by scientists at the University of Glasgow and the University of Melbourne, is a comprehensive database describing over 100 CML samples. It is completely free for researchers to use and share.

Dr Imran Ahmad has received a European Association of Urology (EAU)award.

Tue, 25 Apr 2017 11:34:00 BST

Congratulations to Dr Imran Ahmad, CRUK Clinician Scientist and Senior Lecturer in Uro-Oncology at the Institute of Cancer Sciences

Inherited genes may cause more cancer than previously thought

Wed, 15 Feb 2017 18:00:00 GMT

A new study into a rare type of pancreatic cancer reveals that we may inherit more than twice the number of ‘cancer genes’ than experts previously thought.

The new Miss Scotland, Lucy Kerr, has chosen Action Medical Research as her charity to fundraise for this year.

Tue, 06 Dec 2016 16:08:00 GMT

The new Miss Scotland, Lucy Kerr, has chosen Action Medical Research as her charity to fundraise for this year. Lucy has identified our project - 177Lu-DOTATATE combined with radiosensitisers to enhance targeted radiotherapy of neuroblastoma - of particular interest to her.

BACR/AstraZeneca Award

Thu, 17 Nov 2016 10:35:00 GMT

The BACR/AstraZeneca/Young Scientist Frank Rose Award has been won by Oliver Maddocks. The purpose of this award is to recognise and reward the achievements of an individual whose work has made significant contributions to translational (laboratory - clinic) cancer research.

SPECTRE study - A study looking at Combined SuPpression of cholEsterol bioavailability and androgen deprivation therapy to treat CastraTion Resistant prostatE cancer

Thu, 15 Dec 2016 11:44:00 GMT

SPECTRE - A study looking at Combined SuPpression of cholEsterol bioavailability and androgen deprivation therapy to treat CastraTion Resistant prostatE cancer

Newton Fellowship award

Tue, 08 Nov 2016 12:42:00 GMT

Mohammed Mansour has secured a Newton International Fellowship from the Royal Society/British Academy and will be joining Dave Bryant’s lab from Tanta University, Egypt in March 2017 for 2 years.

National Cancer Research Institute (NCRI) Initiatives

Thu, 06 Oct 2016 14:00:00 BST

Two clinician scientists from the Institute of Cancer Sciences have been appointed to chair exciting initiatives run by the National Cancer Research Institute (NCRI).

Major collaboration including CRUK and UofG to trial new combination of immunotherapy drugs

Fri, 30 Sep 2016 15:49:00 BST

Cancer Research UK has today announced its first cross-company deal as part of its Experimental Cancer Medicine Centre (ECMC) Combinations Alliance. MSD, Verastem and Cancer Research UK will trial a new combination of immunotherapy drugs in mesothelioma, non small cell lung and pancreatic cancers. The trial will run through the ECMC network at centres in Edinburgh-Dundee, Southampton, Glasgow, Leicester and Belfast.

Precision medicine breakthrough for Chronic Myeloid Leukaemia

Thu, 15 Sep 2016 16:29:00 BST

Scientists at the University of Glasgow have made a second significant breakthrough in the treatment of chronic myeloid leukaemia – using precision medicine to kill more than 90% of chronic myeloid leukaemia (CML) stem cells. The results are published today in the high impact journal Cancer Discovery.

Pancreatic cancer trial to make tumours more sensitive to treatment

Mon, 29 Aug 2016 13:55:00 BST

Cancer Research UK (CRUK) launches a first-of-its-kind pancreatic cancer clinical trial to make cancer cells more responsive to chemotherapy and radiotherapy, with University of Glasgow researcher Professor Jeff Evans as the chief investigator.

Scientists identify drugs to target ‘Achilles heel’ of Chronic Myeloid Leukaemia cells

Fri, 10 Jun 2016 15:02:00 BST

New research, by the Universities of Glasgow and Manchester, has revealed an ‘Achilles heel’ of Chronic Myeloid Leukaemia (CML) and found drugs to successfully target this weakness and eradicate the disease in mice.

BBC Earth Big Questions - How cancer was created by evolution

Tue, 07 Jun 2016 12:13:00 BST

The cells inside a tumour change and evolve just like animals in the wild. Understanding how this works could help us stop cancer in its tracks. By Melissa Hogenboom 2 June 2016

Myeloma UK establishes two new Health Services Research partnerships

Thu, 02 Jun 2016 11:56:00 BST

Myeloma UK has awarded grant funding to research teams based at Manchester Royal Infirmary and at the National Institute for Health and Care Excellence (NICE) for two new studies in partnership with Myeloma UK.

Press Release - Myeloma UK awards £118,000 research grant to Manchester Royal Infirmary

Thu, 02 Jun 2016 12:04:00 BST

Press Release - Myeloma UK awards £118,000 research grant to Manchester Royal Infirmary

Glasgow Science Festival - Bench to Bedside: Revealing Translational Medicine, 17th June 2016 - Wolfson Wohl Cancer Research Centre

Wed, 08 Jun 2016 15:53:00 BST

Glasgow Science Festival - Bench to Bedside: Revealing Translational Medicine, 17th June 2016 - Wolfson Wohl Cancer Research Centre

First Annual ICS PhD Student Summit secures funds

Tue, 29 Mar 2016 15:02:00 BST

First Annual ICS PhD Student Summit secures funds. The UofG Chancellor’s Fund has awarded £3,000 to the Institute of Cancer Sciences towards the organisation of the First Annual ICS PhD Student Summit.

Identification of four Pancreatic Cancer subtypes offers new treatment insight

Thu, 25 Feb 2016 14:30:00 GMT

Researchers at the University of Glasgow have made a breakthrough reclassification of Pancreatic Cancer, offering new opportunities to treat the disease.

World Cancer Day 2016

Thu, 04 Feb 2016 09:40:00 GMT

World Cancer Day 2016 is Thursday 4th February and linking with the NIHR@10 campaign, the ECMC Secretariat have created a short video exploring the landscape of experimental cancer medicine in the UK

Congratulations to our 2014-15 MSc graduates

Thu, 19 Nov 2015 10:26:00 GMT

Many of our MSc Cancer Sciences class of 2014-15 returned for the Winter Graduation Ceremony at the Bute Hall on 1st December 2015.

Major prize for Prof Tessa Holyoake

Thu, 19 Nov 2015 10:26:00 GMT

Professor Tessa Holyoake has been awarded the Scottish Cancer Foundation’s inaugural prize.

New Msc Cancer Sciences gets underway

Thu, 25 Sep 2014 15:42:00 BST

The new MSc in Cancer Sciences was launched on the 17th of September. ICS are pleased to welcome twenty four students from around the world onto our programme, which takes a “bench to bedside” approach, enabling graduates to work within a multidisciplinary environment of world-leading scientists and cancer-specialists.

The Wolfson Wohl Cancer Research Centre has officially opened

Tue, 06 May 2014 13:56:00 BST

Cancer research in Glasgow has received a massive boost with the official opening of a new centre to help find cures for the various forms of the disease.

Cancer In The 21st Century - The Genomic Revolution

Tue, 25 Mar 2014 12:54:00 GMT

A free six week online course is in progress, which focuses on how modern genetics has revolutionised approaches to the detection and treatment of cancer. It will feature a range of guest lecturers from the College of MVLS including active researchers in the Institutes of Cancer Sciences. The course is suitable for anyone with an interest in cancer genomics, including those interested in applying for the MSc in Cancer Sciences.

New MSc course in Cancer Sciences is receiving applications for a 2014 start

Tue, 25 Mar 2014 12:24:00 GMT

Masters in Cancer Sciences is taking applications for a 2014 start. This programme takes a “bench to bedside” approach, enabling graduates to work within a multidisciplinary environment of world-leading scientists and cancer-specialists to address the latest challenges in cancer diagnosis, research and treatment, including the complexities of early and effective diagnosis, identifying cancer- and patient-specific treatment, and overcoming partial response and recurrence after treatment.

'MicroRNA' could be key target for bowel cancer treatment

Tue, 06 May 2014 14:14:00 BST

A tiny genetic molecule known as a microRNA plays a central role in bowel cancer and could be key to developing new treatments for the disease.

Reducing the use of animals in research

Tue, 29 Apr 2014 11:37:00 BST

Scientists across the UK and the world are working on new techniques to refine, reduce and replace the use of animals in the lab.

Unite Against Cancer sponsor a new MSc Cancer Sciences scholarship

Fri, 04 Apr 2014 10:31:00 BST

Unite Against Cancer has generously agreed to fund a £20,000 scholarship for a student of the new MSc Cancer Sciences programme. Unite Against Cancer is a Glasgow-based charity that was set up in 2012 to fund research into new cancer treatments.

High School of Glasgow pupils visit the Institute

Mon, 31 Mar 2014 23:17:00 BST

On Thursday 27th March, ICS researchers welcomed a group of 6th form biology advanced higher pupils from the High School of Glasgow to the Wolfson Wohl Cancer Research Centre.

The Beatson welcomes ambitious new charity in the fight against cancer

Tue, 25 Mar 2014 12:13:00 GMT

A new charity has been launched to attract more than £20m of funding over the next five years for the Beatson West of Scotland Cancer Centre.